Dermatological
1890 — Sigmund Pollitzer and Viktor Janovsky, Germany
Acanthosis nigricans, characterized by dark, velvety skin changes in body folds, was first formally described in the late nineteenth century by European dermatologists who were struck by its distinctive appearance and its frequent association with internal malignancies. For much of the early twentieth century, the condition was understood primarily as a harbinger of hidden cancer, a reputation that shaped how physicians approached and classified it for decades. Later historical investigations gradually revealed that the condition's associations were more varied than early observers had appreciated, prompting ongoing reclassification throughout the twentieth century.
Historical Narrative
The earliest coherent medical descriptions of acanthosis nigricans appeared in the German and Austrian dermatological literature of the 1880s and 1890s, a period of extraordinary productivity for European skin medicine as the discipline crystallized around careful clinical observation and histological examination. The Austrian dermatologist Moritz Kaposi, already known for describing the vascular tumor that bore his name, was among the first to draw systematic attention to the characteristic skin changes, and the German physician Heinrich Auspitz also contributed early observations. In 1890, two German physicians — Sigmund Pollitzer and Viktor Janovsky — published independent descriptions of the condition that are typically cited as the foundational clinical accounts, providing detailed characterizations of the pigmented, thickened, papillomatous changes appearing in the axillae, neck, and other flexural regions.
Early observers were immediately struck by the frequency with which affected patients were found to harbor internal carcinomas, particularly of the gastrointestinal tract. This association was so prominent in the initial case series compiled by Pollitzer, Janovsky, and their contemporaries that acanthosis nigricans became categorized first and foremost as a paraneoplastic phenomenon — a skin manifestation that signaled malignant disease elsewhere in the body. For clinicians working at the turn of the twentieth century, encountering the skin finding was understood as an urgent prompt to search for an underlying tumor, and the prognosis implied by a diagnosis of acanthosis nigricans was correspondingly grave.
This malignancy-centered understanding dominated the medical literature through the early and middle decades of the twentieth century, shaping how the condition appeared in dermatological textbooks and how physicians responded to its presence. However, as case accumulation continued across European and North American medical centers, clinicians began noting patients who displayed identical skin changes without any discoverable malignancy, and in some instances without any obvious serious underlying disease at all. These observations created pressure to subdivide the condition into distinct types, and various classification schemes were proposed through the mid-twentieth century distinguishing a malignant type from a benign type and from forms associated with other systemic states.
The transformation in understanding accelerated in the latter half of the twentieth century as researchers began systematically investigating the relationship between acanthosis nigricans and metabolic states characterized by insulin resistance. Investigators examining patients with obesity, certain endocrine disorders, and related conditions found high rates of the skin changes, and laboratory research began to suggest that elevated circulating insulin could stimulate cutaneous receptors in ways that produced the characteristic epidermal thickening. This mechanistic hypothesis reframed the condition from a primarily oncological curiosity into a skin finding with far broader metabolic associations.
The historical trajectory of acanthosis nigricans thus moved across roughly a century from a phenomenon understood almost entirely through its link to hidden malignancy, through a period of taxonomic uncertainty as non-malignant cases multiplied in the literature, toward a more complex appreciation of the multiple pathways through which the characteristic skin changes could arise. Each phase of this evolution reflected the broader diagnostic and investigative tools available to physicians of each era, from the histological microscopy of the late nineteenth century to the endocrinological and biochemical methods of the late twentieth.
Key Historical Figures
Historical narrative only — this page describes how Acanthosis nigricans was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.